title: [Contribution of LHRH analogs in prostate cancer treatment].
abstract: The contribution of LHRH analogs is enormous in prostate cancer management at nearly all stages of the disease, the Leading cancer in males over 50 years of age. They make it possible to use hormone therapy reliably, with Little morbidity, and can be reversed. Their use can be immediate or delayed, continuous or intermittent, whether or not they are associated with an antiandrogen, and can be associated with chemotherapy for patients who have reached the stage of hormone-refractory prostate cancer.
authors.affiliation: Service d'urologie, hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France. marc.zerbib@cch.aphp.fr
authors.forename: M
authors.initials: M
authors.lastname: Zerbib
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009919:Orchiectomy; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000628:therapy*
chemical_list: D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone